Ocular, Periocular and Cutaneous Tolerance and Efficacy of Formula 2039002 10 in Patients With Palpebral Eczema
NCT05540496 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 41
Last updated 2022-09-14
Summary
The eyelids are particularly susceptible to eczema. Eyelid eczemas also called palpebral eczema, are a common condition that causes the skin on or around the eyelid to become dry, itchy, and irritated.
The study aims at evaluating the ocular and peri-ocular tolerance and the efficacy of the investigational product under normal conditions of use in participants with a palpebral eczema ground.
This open-labeled, multicentric study was conducted under dermatological and ophthalmological control in Caucasian subjects over 18 years of age, of all skin types and having a sensitive skin, especially on eye contour. The investigational product was to be applied twice daily on eyes contour for 4 weeks.
Conditions
- Eczema Eyelid
Sponsors & Collaborators
-
Cosmetique Active International
lead INDUSTRY
Principal Investigators
-
Meryem Nili · Dermatech
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-01-11
- Primary Completion
- 2021-04-17
- Completion
- 2021-04-17
Countries
- Georgia
Study Locations
More Related Trials
-
Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema)
NCT03569293 ·Status: COMPLETED ·Phase: PHASE3
-
Frequency of Palpebral Involvement in Adult With Atopic Dermatitis
NCT04826744 ·Status: RECRUITING
-
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986326 in Participants With Atopic Dermatitis
NCT06248814 ·Status: COMPLETED ·Phase: PHASE1
-
A Dose-Finding Study of GSK2894512 Cream in Subjects With Atopic Dermatitis (AD)
NCT02564055 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Determine the Safety & Efficacy of ZPL-5212372 in Healthy Subjects and in Subjects With Atopic Dermatitis
NCT02795832 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of Dupilumab to Demonstrate Efficacy in Subjects With Nummular Eczema
NCT04600362 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study to Test the Effect of 2 Different Doses of Topical GW870086X on Atopic Dermatitis Also Including a Postive Control and a Placebo
NCT01299610 ·Status: COMPLETED ·Phase: PHASE2
-
A Study for a Topical Medication Versus Placebo in Patients With Hand Dermatitis
NCT03703895 ·Status: COMPLETED ·Phase: PHASE4
-
Cosmetic Study to Improve the Appearance of Skin Afflicted With Mild to Moderate Atopic Dermatitis.
NCT03268174 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of CD5024 0.3% Cream in Subjects With Atopic Dermatitis
NCT03250624 ·Status: COMPLETED ·Phase: PHASE2
-
Skin Efficacy and Tolerability of a Cosmetic Product Combination Over 3 Months in Subjects With Atopic Eczema
NCT05790083 ·Status: UNKNOWN ·Phase: NA
-
Skin Irritation Study of GSK2894512 Cream
NCT02637206 ·Status: COMPLETED ·Phase: PHASE1
-
Observational Study of Conjunctivitis in the Setting of DUPIXENT® Treatment for Atopic Dermatitis
NCT04287608 ·Status: COMPLETED
-
KM-001 Cream for Treatment of Pruritus in Adult Patients With Lichen Simplex Chronicus (LSC)
NCT05454462 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment of Skin Tolerance and Efficacy of a Cosmetic Product After 5 Days of Use on Subjects With Atopic Dermatitis
NCT05807113 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
NCT01756898 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of MEDI3506 in Adult Subjects With Atopic Dermatitis
NCT04212169 ·Status: COMPLETED ·Phase: PHASE2
-
Tolerance Evaluation of a Nighttime Moisturizing Balm on Babies and Adults With Eczema
NCT02357940 ·Status: COMPLETED ·Phase: NA
-
A Study To Determine The Safety, Tolerability, Skin Irritation Potential, And PK Following Topical Application Of PF-07038124 In Healthy Participants
NCT04135560 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy Study of ImCOOH Cream in Patients Suffering From Moderate Atopic Dermatitis
NCT00583895 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety of LAS41003 in the Treatment of Superficial Infected Eczema
NCT01020994 ·Status: COMPLETED ·Phase: PHASE2
-
Identifying Atopic Dermatitis Patients at Risk for Developing Conjunctivitis During Dupilumab Treatment
NCT04276623 ·Status: RECRUITING
-
Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis
NCT03985943 ·Status: COMPLETED ·Phase: PHASE3
-
SAR231893-LPS15497- "Dupilumab Effect on Sleep in AD Patients"
NCT04033367 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Effect, Safety and Tolerability of GSK1070806 in Atopic Dermatitis
NCT04975438 ·Status: COMPLETED ·Phase: PHASE1